Global Percutaneous Coronary Intervention Devices Market 2018-2026: Global Burden of Heart Diseases, Diabetes and Coronary Artery Disease Driving Market Growth

DUBLIN, June 14, 2018 /PRNewswire/ --

The "Global Percutaneous Coronary Intervention Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.

The global percutaneous coronary intervention devices market was valued at US$ 5.98 Bn in 2017, and is expected to reach US$ 8.70 Bn by 2026, expanding at a CAGR of 4.3% from 2018 to 2026.

This is mainly driven by increase in global burden of heart diseases, diabetes and coronary artery disease. Percutaneous coronary intervention is a non-surgical technique to prevent narrowing of the coronary arteries by removing the plaque using PTCA balloon catheters and placement of coronary stents.

Based on device types, the global percutaneous coronary intervention devices market is segmented into coronary stents, PTCA catheters, and coronary guidewires. These devices are used in the treatment of coronary artery disease during PCI procedures. Coronary stents segment is expected to grow at substantial pace in the forecast period due to introduction of the new products in the market.

Based on the end-users, the global percutaneous coronary intervention devices market is segmented into hospitals, ambulatory surgical centers (ASCs), and catheterization labs. In terms of market value, hospitals segment is expected to dominate the global percutaneous coronary intervention devices market for the year 2017 due to greater availability of the skilled professionals required to perform the procedure, and greater footfall of target patients in hospitals. However, as the healthcare infrastructure is expanding in both developed and developing economies, and greater preference for specialized treatment locations is observed in both patients and care-givers, the dominance of hospitals is expected to be challenged by catheterization labs.

Major players in the global percutaneous coronary intervention devices market include Abbott Laboratories, Inc., B. Braun Melsungen AG, Biosensors International Group, Biotronik SE & Co. KG, Boston Scientific Corporation, Getinge AB, Johnson & Johnson, Medtronic plc, St. Jude Medical LLC, and Terumo Corporation.

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Percutaneous Coronary Intervention Devices Market: Market Dynamics and Outlook

Chapter 4. Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 - 2026 (US$ Bn)

Chapter 5. Percutaneous Coronary Intervention Devices Market, by End-user, 2016 - 2026 (US$ Bn)

Chapter 6. Percutaneous Coronary Intervention Devices Market, by Geography, 2016 - 2026 (US$ Bn)

Chapter 7. Company Profiles

• Abbott Laboratories
• B. Braun Melsungen AG
• Biosensors International Group
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Getinge AB
• Johnson & Johnson
• Medtronic plc
• St. Jude Medical.
• Terumo Corporation

For more information about this report visit https://www.researchandmarkets.com/research/4bbrkr/global?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets